depression

9511213674_31a3c06cc7_z

Introduction

Clinical, unipolar depression is more than just feeling low for a day or two.

Depression is characterised as episodes of sadness, loss of interest and pleasure, often including feelings of low self-worth. Depression can also include a range of physiological symptoms, such as fatigue, pain, diminished appetite, lack of interest in sex, disturbed sleep, and poor concentration.

The World Health Organisation estimates that, globally, as many as 350 million people are affected at any given time, with one person in 20 reporting an episode of depression in a 12 month period (in a global sample of 17 countries). They describe depression as the leading cause of disability worldwide.

What we know already

We know that, despite the considerable global burden of depression, not everybody receives treatment, with figures ranging from 50% to 10% in less developed countries.

Evidence suggests that combined psychological and pharmacological treatments seem to work well. Broadly, we know that psychotherapies work in many cases – but not every time. We know that neurochemical factors, such as serotonergic dysfunction, play an important role in depression, which goes a long way in explaining the efficacy of SSRI treatments.

We also know that depression has a nasty habit of recurrence, and some psychological interventions, such as Mindfulness-Based Cognitive Therapy (MBCT) is recommended particularly for people who have experienced multiple episodes of depression, but not are currently severely depressed.

We know that people living with chronic physical illness are more likely to experience depression, and this combination is linked with poorer clinical outcomes.

Importantly though, we know that people with depression can still enjoy themselves, and a common misconception in depression is that people feel totally awful all of the time.

Areas of uncertainty

There is much still to determine. For example, we know that depression is hereditable, however the extent of heredity versus environmental influences are unclear.

We are also unsure as to the precise mechanisms that determine those who respond best to treatments, be they psychopharmacological, or psychological, or both.

What’s in the pipeline?

Despite advances in our understanding of depression, and how it is treated, it remains a highly recurrent difficulty, with many people not achieving complete remission between episodes.

Preventative interventions, either physiological, or psychological, may improve people’s resilience to depression, particularly those identified as being highly prone.

References

Cuijpers, P. (2015). Psychotherapies for adult depression: recent developments. Current Opinion in Psychiatry, 28, 24-29. [Abstract]

Naylor, C., Parsonage, M., McDaid, D., Knapp, M., Fossey, M. and Galea, A. (2012) Long-term conditions and mental health: the cost of co-morbidities. The King’s Fund, London, UK [PDF]

World Health Organisation (2015).Factsheet 369: Depression [Link]

Photo Credits

Sascha Kohlmann CC BY 2.0

Acknowledgement

Written by: Patrick Kennedy-Williams
Reviewed by:
Last updated: Nov 2015
Review due: Sep 2016

Our depression Blogs

Psychotherapy and antidepressant tapering can help people at risk of depression relapse, but more evidence needed before we can provide personalised treatment

reza-biazar-eSjmZW97cH8-unsplash

Jessica Scaife reviews a individual patient data meta-analysis exploring the continuation of antidepressants versus sequential psychological interventions to prevent relapse in depression.

[read the full story...]

Isolation and loneliness in women living with perinatal depression: how can we heal our dislocated self and relationships?

camila-cordeiro-fENq_PIhPSo-unsplash

In her debut blog, Jacqueline Kent-Marvick reviews a qualitative study exploring the role of isolation and loneliness in the narratives of women diagnosed with perinatal depression.

[read the full story...]

The benefits and harms of antidepressants for youth depression and anxiety #ActiveIngredientsMH

Sad,Teenager,Girl

Mark Horowitz and Joanna Moncrieff consider a new #ActiveIngredientsMH review published today in The Lancet Psychiatry, which looks at the knowns and unknowns of antidepressant treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.

[read the full story...]

Can ketamine metabolites and gamma power help predict clinical response for ‘treatment resistant depression’?

girl-with-red-hat-r4A-lJTgXQg-unsplash

Anya Borissova summarises a recent randomised placebo-controlled trial that evaluated ketamine metabolites, clinical response, and gamma power for major depression.

[read the full story...]

Depressive symptoms and negative online disclosures: is the clue in the post?

joshua-hoehne-Uo2ZXh4XOLY-unsplash

A group of UCL MSc students review a recent mixed-methods study which suggests that online disclosure of negative emotions and experiences (posted to Facebook) are linked with depression symptoms in US college students.

[read the full story...]

PTSD, anxiety and depression in UK frontline health care workers during COVID-19

A,Depressed,And,Tired,African,Nurse,Wears,A,Mask,And

In his debut blog, Will Kapurura summarises a paper that explores the impact of COVID-19 on the mental health of healthcare workers in the UK during the early part of the 2020 pandemic.

[read the full story...]

Expertise from outside the Academy: tapering off antidepressants

Senior,Man,Holding,Pharmaceutical,Pills,Over,Isolated,Background,With,Open

Mark Horowitz considers a recent article written by Adele Framer, Founder of SurvivingAntidepressants.org, which describes how best to help people who are tapering off antidepressants.

[read the full story...]

Does shame in childhood affect the risk of adolescent depression and anxiety? #CAMHScampfire

Children,Engage,In,Bullying,Behavior,Towards,A,School,Girl.,Depressed

Douglas Badenoch helps us prepare for another CAMHS Around the Campfire session by exploring a recent twin study on the aetiology of shame and its association with adolescent depression and anxiety.

Follow #CAMHScampfire on Twitter at 5pm BST on Tuesday 20th July for an online journal club discussing this paper. Or sign up now to join the free webinar hosted by ACAMH.

[read the full story...]

Exercise can help reduce depressive symptoms in people who are not clinically depressed

isaac-wendland-7DCZgKyp8vw-unsplash

Ross Nedoma summarises a recent systematic review and meta-analysis exploring the effectiveness of exercise-based interventions in reducing depressive symptoms in people without clinical depression.

[read the full story...]

Turn on, or tune out? Is psilocybin assisted therapy close to becoming a first-line treatment for depression?

reproductive-health-supplies-coalition-V4pVBEHKPo0-unsplash

James Rucker and Sameer Jauhar summarise a recent RCT on the effectiveness of psilocybin assisted therapy versus escitalopram assisted therapy for major depressive disorder.

[read the full story...]